In addition, two latest publications showed that Dnmt3a deletion in a mouse lung cancer model promoted tumor progression but not initiation [30, 31], and Dnmt3a maintained the methylation-dependent repression (MDR) of specific oncogenes which were involved in key steps of lung tumor progression, including angiogenesis, cell adhesion and movement [30]. Here, DNMT3A is linked to lung carcinoma.